Molecule Holdings Inc.

As of July 31, 2023, Molecule Holdings Inc. has 97.78M shares outstanding.

These figures are as of July 31, 2023. The price-to-sales ratio is 0.82, and the price-to-book ratio stands at -0.26.

These figures are as of July 31, 2023. The EV/Sales ratio of 4.02 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Molecule Holdings Inc. trades at an EV/FCF ratio of 10.42, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of July 31, 2023, Molecule Holdings Inc. maintains a current ratio of 0.12, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -103.62, indicating conservative leverage, while an interest coverage ratio of -2.50 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended July 31, 2023. Return on assets (ROA) is negative at -92.41, reflecting losses generated across the asset base. Inventory turnover of 4.30 indicates how many times Molecule Holdings Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended July 31, 2023, Molecule Holdings Inc. posted a gross margin of -25.27, reflecting its pricing power and cost economics. The operating margin of -147.08 and net profit margin of -200.50 provide insight into operational efficiency.

These figures cover the twelve months ended July 31, 2023. Free cash flow yield is negative at -6.73: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 5.72, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Molecule Holdings Inc. shareholders.

Molecule Holdings Inc.'s most recent stock split took place on September 17, 2020 with a 10:1 split ratio.

As of July 31, 2023, Molecule Holdings Inc. has an Altman Z-Score of -11.75, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.